Fusion protein for remodeling antibody glycoform
A fusion protein and antibody technology, applied in the direction of fusion polypeptide, antibody mimic/scaffold, application, etc., can solve problems such as low efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example
[0089] fusion protein
example 1
[0090] Example 1: Production of Fusion Proteins
[0091] Generation of full-length or truncated (IgG binding motif only) containing fusions to fucosidases BF3242 (Table 1), Alfc (Table 2), BT2970 (Table 3), EO0918 (Table 4) and Emfuc3 (Table 5) Fusion proteins of EndoS or EndoS2, as shown in Tables 1 to 5 below.
[0092] Table 1. BF3242 fusion protein
[0093]
[0094]
[0095] a Only the IgG binding domain of endoS or endoS2
[0096] b wild-type endoS or endoS2
[0097] Table 2. Alfc fusion proteins
[0098]
[0099]
[0100] Table 3. BT2970 fusion proteins
[0101]
[0102]
[0103] Table 4. EO0918 fusion protein
[0104]
[0105] Table 5. Emfuc3 fusion proteins
[0106]
[0107] Remodeling of glycans in antibody Fc regions.
example 2
[0108] Example 2: Analysis of fucosidase activity
[0109] The test antibody (ie, Trastuzumab (TRZ)) was treated with endoS2 in Tris-HCl (pH 7.0) at 37°C for 1 hour. The treated antibody was adsorbed on protein A affinity chromatography resin (MabSelect TM ), washed with Tris-HCl (pH 7.4) and eluted with citrate buffer (pH 3.0) for purification. The majority of residual glycans in the Fc region of the resulting antibody are N-acetylglucosamine-fucose (GlcNAc-Fuc). Purified antibodies were treated with fusion protein or natural fucosidase in Tris-HCl buffer (pH 7.0) at 37°C for 16h, followed by heating at 55°C for 20min to inactivate the enzyme activity. The reaction mixture was filtered through a 0.22 μm membrane and the treated antibody was purified by affinity chromatography.
[0110] The content of residual fucose was determined by analyzing the mass of intact protein. TRZ-N / N (TRZ containing two GlcNAc in the Fc region), TRZ-N / NF (TRZ containing one GlcNAc and one GlcN...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com